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Dregimens.We also recommendneurologic consultation in all
patients with cerebral embolism, in particular if hemorrhag-
ic transformation or intracranial bleeding has occurred.
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Dr Marc Ruel (Ottawa, Canada). Dr Misfeld and colleagues
have presented their findings in 375 patients who had surgery
for acute infective endocarditis preoperatively complicated by
cerebral embolism over an 18-year period. This subpopulation
represents roughly a quarter of their operations for infective
endocarditis. The work contains interesting descriptive
information, some of which I will comment on.
When dealing with infective endocarditis there are essentially
2 questions: what technique to do and when to do it. We are getting
much better at answering the first question. We have better antibi-
otics, better hemodynamic treatments, and we know that homo-
grafts are not mandatory, which was confirmed once more in
your study where they were used relatively infrequently. And we
also know that stroke is not a contraindication to surgery. Never-
theless, the perioperative mortality of these operations remains
high, and in your study it was 22%, which is not out of range
but still high indeed.
When to intervene remains the big question. You have shown
that 135 patients, representing roughly 9% of all your operated
infective endocarditis patients, and 36% of the cerebral embolism
subcohort, had asymptomatic cerebral embolism. One of your con-
clusions is that preoperative cerebral imaging is therefore of great
importance. However, it remains to be determined to what extent
cerebral imaging changes the management, provided that you do
not find shift or a bleed on the computed tomography (CT) scan
or magnetic resonance imaging scan.
There are other groups, such as the 1 from Osaka University
presented last year, who found that perioperative hemorrhagic
transformation of a stroke is relatively rare, and you have found
this as well. But I believe that surgeons need to know if there
are characteristics or predictors of what may lead to hemorrhagic
transformation or cause significant brain edema with surgery.
There are groups, for instance, who have used an algorithm
where surgery is delayed if a brain infarct with mass effect is found
on head CT, or if there is an unruptured mycotic aneurysm present
that would be clipped before surgery.
It is clear that more and more research points toward early sur-
gical intervention in the case of infective endocarditis with cere-
bral embolization, on the basis that it does not increase mortality
and may help prevent subsequent stroke.gery c June 2014
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DHere you make no claim, but you point out that preoperative
antibiotic therapy was independently associated with cerebral em-
bolism and, therefore, one should proceed to surgery quickly.
Recent work from the International Collaboration on Endocarditis
revealed a trend toward higher in-hospital mortality when surgery
was performed within 7 days of the stroke at a 22% rate, versus
only 12% when surgery was delayed to a later date.
There has to be some prognostic determinants related to the
brain imaging, to the causative organism, to the status of the pa-
tient, to the valve itself, to the vegetations and their size, or to
the hemodynamics that we just do not know and need to elucidate.
Your research is a step in the right direction, but these many ques-
tions remain.
I have 2 questions. First, do you use the results of the head CT
scan or magnetic resonance imaging scan as mere prognostic in-
formation for the patient and family, or are there some character-
istics that are looked for to delay or perhaps in some cases expedite
surgical intervention?
My second question is related to the first. Clearly not everyone
who has a cerebral embolism and infective endocarditis has to un-
dergo operation; for instance, in previous research only 23% did.
Many patients are fine just with medical treatment. What are the
patient or brain lesion characteristics that would entice you to op-
erate right away versus waiting, perform another intervention such
as neurosurgery first, or not operate at all. For instance, if a patient
is stable with a smaller lesion but has infective endocarditis and ce-
rebral embolism?
DrMisfeld. Indication in Leipzig for performing surgery in this
group of patients is always an individual decision and probably
there are 4 aspects that are important.
First, the clinical presentation: What kind of neurologic compli-
cation is present? Does the patient have low cardiac output? Status
of the other organ systems is important, too. Second, the therapeu-
tic regimen at presentation: Howmany inotropes is the patient tak-
ing and what about the antibiotic regimen? For how long has the
patient been taking antibiotics and what kind of bacteria have
been cultured? Third, the echo images are most important, and it
is probably not only the size of the vegetation, it is especially
the characteristics of the vegetation; mobility, for example. Addi-
tional questions have to be answered: are there multiple vegeta-
tions, are both valves affected, and is an abscess present? This
will all be part of the final decision, as well as the fourth aspect,
the CT scan or magnetic resonance imaging findings. We routinely
perform not only a CT scan of the brain, but also of thewhole body.
With regard to the cranial CT scan we have some sort of insen-
sitivity within the first time after a stroke where the lesions in the
brain are probably not demarked and therefore not visible. You are
also probably not able to detect microbleeds with the CT scan as
you can do with magnetic resonance imaging. Microbleeds have
been proposed to be a risk factor for later cerebral bleeding. How-
ever, CT scans are fast to perform and available everywhere.
I will give you an example. In a patient with a vegetation of
5 mm who has experienced a stroke, we would look at the kind
of vegetation: Is it mobile? We would also look at the CT scan.
If there is no lesion, but a clinical presentation of stroke, a surgeon
is probably within this range of safety (before 72 hours) where the
ischemic region has not been transformed with the potential risk of
hemorrhage. In that patient, we would perform the surgery as soonThe Journal of Thoracic and Caras possible. Some even advocate that in a patient like this surgery
may be protective against stroke by using a heart-lung-machine
with hemodilation, hypothermia, and anticoagulation.
If that patient presents with a stroke and a lesion on the brain, it
depends on the location and the size of the cerebral defect. It has
been suggested that small-size lesions are probably safe, whatever
‘‘small’’ means, so probably 1 to 1.5 cm2 is a small lesion. The
location of the lesion is also important. Is it more peripheral or cen-
tral and are there multiple lesions or not?
It is also most important to consult a radiologist; a cardiologist;
and, if there is a hemorrhagic transformation, the neurosurgeon. In
the end it will be a team decision.
If there is a bigger lesion or multiple small lesions and already a
shift in the brain’s midline or an edema, you probably need to post-
pone the procedure. We would also postpone surgery in the pres-
ence of a hemorrhagic transformation.
At 1 stage you need to balance the increasing the risk of cerebral
complications versus the risk of the operation itself. In these pa-
tients we watch and wait; we closely follow them clinically, with
CT scans and echo. In some patients who had a hemorrhagic trans-
formation and you postpone surgery, it ends up in an ethical ques-
tion of if you operate or not.
Dr Antonio Laudito (Duluth, Minn). I have a question on the
temporal pattern of embolization. Considering your experience
and your review of the literature, are the patients embolizing in
the first 48 hours or, as you say, 72 hours, and then the rate of
embolization goes down? Could you confirm that kind of clinical
scenario and temporal pattern of embolization?
Dr Misfeld. Usually we see the patients very late. We see pa-
tients who already have an abscess or they have embolized or
they have experienced a stroke and then we see them after 1 or 2
weeks.
There is decreasing risk of stroke over time. If a patient has
experienced a stroke once and is following a proper antibiotic
treatment, probably the risk of re-stroke is less than assumed.
Dr Thierry Mesana (Ottawa, Canada). Do you have a
particular recommendation for a prosthetic valve in these patients?
How often would you put in a mechanical valve, and how do you
manage anticoagulation in these patients after surgery?
DrMisfeld.We follow the principle: Be radical and repair what
you have to repair. The other principle is that we aim to drain the
pus if there is an abscess into the mediastinum. So try to avoid
patching abscesses.
It is not as important what kind of valve type you use. If there
is a hemorrhagic transformation before the operation or a very
high risk for that, we choose a biological valve—not a mechan-
ical valve—to avoid anticoagulation. Age is not an issue for us
with regard to valve choice. The patients have to survive the
endocarditis.
We still use the homograft because we believe that without any
artificial material, at least theoretically, this has some benefit with
regard to the risk of reinfection. My advice is that you probably
should stick to the valve type or the procedure you are used to.
If you have never used a homograft before, you probably should
not use a homograft in an endocarditis scenario with root abscess.
If the endocarditis only affects the cusps of the aortic valve, and
there is no brain lesion or hemorrhage, then we would follow our
normal regimen of putting in biological or mechanical valves.diovascular Surgery c Volume 147, Number 6 1845
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patients?
Dr Misfeld. No, but our overall number of mechanical valves
for younger patients without endocarditis is already very, very low.
Dr Harold Lazar (Boston, Mass). I have 1 final question. I
wholeheartedly agree with you about running patients through a
scanner when they come in with endocarditis. I have always
been amazed to see other areas. How often have you seen other
embolic sites associated with cerebral emboli? How often do
you see it just as 1 area? In the presence of multiple emboli,1846 The Journal of Thoracic and Cardiovascular Surmultiple systems involved, the brain, spleen, usually kidney, would
that make you want to operate earlier than if you just saw 1 isolated
area?
DrMisfeld. Excellent question. If there is no lesion of the brain
but emboli are present in the spleen and kidney, for example, then
you can assume that probably emboli are present in the brain that
have not been detected yet by CT scan or they are too small. In
more than one-third of cases we were able to find spleen emboli-
zation or abscesses and we had to take the spleen out in one-third
of these patients.gery c June 2014
